Exosome-based Omic Signatures Of Disease Activity In Cardiac Sarcoidosis (EXODACS)

Overview

About this study

The purpose of this study is to develop a prospective cohort of patients with and without cardiac sarcoidosis as well as active and inactive disease to develop a prospective biobank from which exosome analysis of peripheral blood will derive unique biomarkers of disease activity in cardiac sarcoidosis.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

* Adults ≥18 years.
* Patients referred to the Cardiac Sarcoid Clinic with a clinical suspicion or a previously confirmed diagnosis of cardiac sarcoidosis.
* Undergoing FDG-PET as part of standard care.
* Ability to provide informed consent.

Exclusion Criteria

• Inability to provide informed consent.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Andrew Rosenbaum, M.D.

Open for enrollment

Contact information:

Anna Pick

5072550630

pick.anna@mayo.edu

More information

Publications

Publications are currently not available